article
13 December 2017 | By Dr. Paul Wylie (Head of Applications at TTP Labtech)
Hits identified in high-throughput screens are evaluated within the hit-to-lead phase of drug discovery, where they undergo an iterative optimisation process employing a variety of techniques to identify promising lead compounds to move forward to the lead optimisation phase.